We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 1,688

Inventive step: how high is the obviousness threshold?
  • Bird & Bird
  • Australia
  • July 2 2015

As part of the long running legal battle in Australia concerning the validity (and infringement) of a series of second generation patents in respect


Full Court dismisses Garford’s appeal and upholds decision that patent claims are invalid
  • Davies Collison Cave
  • Australia
  • July 2 2015

The Full Federal Court has dismissed an appeal by Garford against the decision by Yates J that claims of its patent were invalid, and that it made


Patent opposition roundup 25 June 2015
  • Phillips Ormonde Fitzpatrick
  • Australia
  • June 30 2015

An Australian Patent Opposition, Revocation and Extension of Term Round-Up from the Patent Office Journal dated 25 June 2015. If you wish to oppose


High Court considers inventive step in Australia
  • Spruson & Ferguson
  • Australia
  • June 26 2015

Last month, on 13 and 14 May 2015, the High Court of Australia heard the Appeal in the rosuvastatin case from the Full Federal Court decision


Seeking a patent term extension may cut it short
  • Freehills Patent Attorneys
  • Australia
  • June 23 2015

A hidden catch to Australia’s generous regime for extension of term of pharmaceutical patents is that requesting an extension of term can act as a


Innovation patents - sticking the boot in
  • Davies Collison Cave
  • Australia
  • June 18 2015

In 2014, I wrote an article entitled "Innovation patents - useful but unloved by some" in which I discussed the Report published in May 2014 of the


High Court of Australia hears Myriad appeal
  • Spruson & Ferguson
  • Australia
  • June 16 2015

The High Court of Australia today heard the long anticipated appeal from the unanimous decision of a 5-judge bench of the Full Federal Court to allow


Pharmaceutical patentee faces damages claim from Australian government for blocking generic’s entry
  • Fisher Adams Kelly
  • Australia
  • June 16 2015

A series of events has led to the Commonwealth of Australia attempting to recover damages from the bio pharma company, Sanofi-Aventis, to the tune of


High Court to consider if isolated genes are patentable
  • Gilbert + Tobin
  • Australia
  • June 15 2015

The High Court will hear oral argument in the D'Arcy v. Myriad Genetics Inc & Anor appeal on Tuesday, 16 - Wednesday, 17 June 2015 before all 7 High


The benefits of Australian innovation patents
  • Phillips Ormonde Fitzpatrick
  • Australia
  • June 15 2015

It is the low validity level of innovation patents which provides benefit to patentees. However, there are additional benefits including the speed of